Dr. Tom Frieden
In a development that raises a host of ethical issues, Spain announced it had obtained a scarce U.S.-made experimental Ebola drug to treat a Spanish missionary priest infected with the killer virus.
The Centers for Disease Control and Prevention has issued its highest alert activation over the Ebola outbreak.
Citing an anthrax scare and a recurring problem with safety, the Centers for Disease Control and Prevention on Friday shut down two research labs and stopped shipping highly dangerous germs to other labs.
The nation’s disease detectives are beginning a program to try to outsmart outbreaks by routinely decoding the DNA of potentially deadly bacteria and viruses.